PROF vs XRAY · rev $10.7M vs rev $3.68B
Profound Medical Corp (PROF) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
PROF currently screens at market cap $238.7M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the PROF and XRAY stock pages for the full models.
Not investment advice.